Profil
Wyle Solomon joined Nordic Biotech June 2007 to focus on the investment process and post-investment follow-up.
He has an extensive experience in pharmaceutical development, regulatory affairs and business development obtained through leadership positions at large, mid-sized, and start-up pharmaceutical companies.
Mr Solomon was formerly employed by Mylan Laboratories where he initially directed the regulatory affairs function for Mylan Technologies, a specialty pharmaceutical division located in Vermont.
Concurrent to completing his MBA in 2006, he moved into Commercial and Business Development for Mylan Technologies where he was responsible for identifying and analyzing market and project opportunities and the development and maintenance of alliances.
Wyle Solomon previously headed the regulatory affairs and pharmaceutical development functions at Achillion Pharmaceuticals in Connecticut, and held positions of increasing responsibility at Bristol-Myers Squibb in New Jersey, as a scientist in oncology drug discovery and in regulatory affairs.
Mr Solomon holds an MSc from Temple University School of Pharmacy in Pennsylvania and an MBA from McGill University School of Management in Montreal.
Anciens postes connus de Wyle Solomon
| Sociétés | Poste | Fin |
|---|---|---|
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Corporate Officer/Principal | 31/07/2012 |
| FORWARD PHARMA A/S | Directeur/Membre du Conseil | - |
Formation de Wyle Solomon
| Temple University (Pennsylvania) | Graduate Degree |
| McGill University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
